News Detail
Mumbai, 3 Jan 2024: Glenmark Pharmaceuticals said on Wednesday it has launched in India the first biosimilar of popular anti-diabetic drug Liraglutide to lower the cost of therapy by some 70 per cent.
The drug, marketed under the brand name Lirafit, has rec......
View Details
Source : Business Standard
Glenmark Pharma
Glenmark Pharmaceuticals
Diabetes
Diabetes drug
Biosimilar launch
Pharmaceuticals firms
Lirafit
Glenmark Pharma share price
Glenmark Pharma news
Glenmark Pharma updates
Pharma sector
Related News
- Counterfeiting of medical devices is a severe offense that jeopardizes human lives: Delhi HC (12-03-2025)
- Three Medicines claimed to cure ‘Urinary Stones’ and ‘Rheumatism’ seized in Telangana (12-03-2025)
- Voluntary recalls initiated after FDA testing of acne products for benzene (12-03-2025)
- NPPP, 2012 Lays down principles for regulation of drugs prices: Anupriya Patel in Rajya Sabha (12-03-2025)
- Health department orders to recall batch of ‘spurious Telma AM 40’ used for hypertension (12-03-2025)
- Zydus Life inks pact to acquire majority stake in Amplitude Surgical (12-03-2025)
- Steps taken to prioritize Research on Fungal Infections (12-03-2025)
- 1500 Pregabalin capsules seized from four places, four accused arrested (12-03-2025)
- India ranked 11th in global pharma exports in 2023: Anupriya Patel (12-03-2025)
- ED arrests 2 from Lucknow for shipping 'banned' drugs to US clients (12-03-2025)